New: NCI-funded clinical trial search
Mednet Logo

Would you favor radiation or immune modulating treatment like imiquimod to treat an uncomplicated basal cell carcinoma on the nose in an elderly patient for whom you'd like to avoid surgery?

4 Answers
Mednet Member
Dermatology · The Skin Surgery Center
Answered on

If my patient was concerned about deformity, with 10 to 15 years of life remaining, unquestionably, I would recommend radiation.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Dermatology · University of Washington School of Medicine
Answered on

Would depend on size, treatment goal and general health/condition of patient.

Radiotherapy is in general better in terms of cure and likely easier for the average patient to tolerate if logistical issues are discounted.

If it is a smaller lesion, a simple curettage and electrodesiccation is a reasonable alternative. Can be done at the time of the biopsy/clinical evaluation. Reasonable cure rate, and acceptable cosmetic outcome in most cases.

Join for free or sign in to see the full answer

Mednet Member
Dermatology · Front Range Dermatology Associates
Answered on

I like Dr. @Dr. First Last's and Dr. @Dr. First Last's - sometimes will combine -biopsy/ED&C followed by imiquimod if it is on a sebaceous nose where it is hard to ensure adequate tx - couple case reports.

I do find the most problematic thing about these patients is wound care. Often, they are brought in by the nursing home or family because the lesion bleeds. For these patients, IGSRT is great because wound is managed during the treatment and has very high cure rates.

For nodular BCCs for patie...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Dermatology · University of Iowa
Answered on

Agree — also have seen excellent outcomes as well with application of imiquimod qhs for 6-12 weeks for bccs with non-high risk pathology.

Join for free or sign in to see the full answer